Pharmacogenomics deals with the questions of whether an individual's genetic make-up affects the efficacy of drugs and/or how to leverage genetic information to optimize drug therapies. The buzz word is: Personalized medicine. The EU is now making a total of €15m available for driving the practical implementation of genetic knowledge to improve therapeutic decision-making. This supports the European U-PGx (Ubiquitous Pharmacogenomics) consortium. bio.logis Genetic Information Management GmbH, based in Frankfurt am Main, Germany, is a member of this consortium and has been concentrating on the issue for years, with a specific focus on developing genetic information management systems. bio.logis will receive €2.4m from these funds to implement its Genetic Information Management Suite (GIMS) along with technologies for genotyping in selected hospitals across Europe (the Netherlands, UK, Austria, Greece, Italy, Spain, Slovenia) for application in day-to-day clinical operations.